Myopia Treatment Global Market Report 2025

Myopia treatment involves medical or corrective methods designed to address or manage myopia, commonly known as nearsightedness. This refractive error causes distant objects to appear blurry while nearby objects remain clear. The primary aim of myopia treatment is to enhance vision and improve quality of life by correcting refractive errors. Additionally, it focuses on controlling the progression of myopia, thereby reducing long-term dependence on corrective lenses for better vision health.

The primary categories of myopia treated include simple myopia, high myopia, and pathological myopia. Simple myopia, caused by an elongated eyeball or an overly curved cornea, results in blurry distant vision and can be treated with corrective lenses or refractive surgery. Treatment options include eyeglasses, contact lenses, refractive surgery, laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and orthokeratology (Ortho-K). These treatments are administered through various methods, such as oral or parenteral routes, among others. Distribution channels include direct tender and retail sales, catering to end users such as hospitals, clinical laboratories, physician offices, and reference laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The myopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia treatment market statistics, including the myopia treatment industry global market size, regional shares, competitors with the myopia treatment market share, detailed myopia treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the myopia treatment industry. This myopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The myopia treatment market size has grown strongly in recent years. It will grow from $17.82 billion in 2024 to $19.52 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to an increase in the geriatric population, increasing government awareness programs, increasing awareness of myopia treatment, increasing investment in research and development, and rising incidence of distance vision impairment.

The myopia treatment market size is expected to see strong growth in the next few years. It will grow to $27.9 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the increasing occurrence of distance vision impairment, increasing use of digital channels, rising healthcare infrastructure, rising incidence of myopia, and increasing cases of vision loss. Major trends in the forecast period include the adoption of rigid gas-permeable contact lenses, advancement in light-based therapies, cutting-edge research investigating the genetic factors, the adoption of digital platforms and apps, and development in atropine eye drops.

The forecast of 9.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pediatric ophthalmology by inflating prices of atropine eye drops and myopia control spectacles developed in Singapore and France, resulting in progressive vision deterioration and higher long-term eye care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the myopia treatment market is anticipated to be driven by the rising levels of screen time. Screen time refers to the duration individuals spend using devices equipped with screens, such as smartphones, tablets, computers, and televisions. Factors contributing to this increase include the growing popularity of streaming services, social media platforms, remote work, and virtual meetings. Myopia treatments are beneficial in mitigating eye strain and discomfort caused by extended screen use, enhancing visual clarity, focus, and overall comfort. For example, in October 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based government agency, revealed that between July 2021 and December 2023, 50.4% of teenagers aged 12-17 reported spending four or more hours daily on screens. Additionally, 22.8% spent three hours, 17.8% spent two hours, 6.1% spent one hour, and 3.0% spent less than one hour per day on screens. This growing screen time trend is a significant factor fueling the expansion of the myopia treatment market.

Leading companies in the myopia treatment market are concentrating on developing innovative products, such as optical biometers, to improve diagnostic accuracy and provide personalized treatments. Optical biometers utilize light to assess eye parameters such as axial length and corneal curvature, aiding in the diagnosis and monitoring of eye conditions. For example, in February 2023, NIDEK Co., Ltd., a Japanese company specializing in ophthalmic products, introduced the AL-Scan M and MV-1 devices. The AL-Scan M features 3D auto-tracking and auto-shot capabilities, allowing for efficient and user-friendly measurements similar to those of an autorefractor. These enhancements boost patient throughput, especially for younger patients. The AL-Scan M is designed for precise axial length measurements, which are vital for tracking myopia progression. Additionally, it integrates smoothly with the MV-1 Myopia Viewer software, facilitating the tracking of treatment history and patient behavior.

In January 2023, CooperVision, Inc., a US-based producer of soft contact lenses, acquired SynergEyes, Inc. for an undisclosed sum. This acquisition is intended to bolster CooperVision's specialty contact lens portfolio and reinforce its standing in the advanced ocular care market. SynergEyes, Inc., also based in the US, specializes in manufacturing contact lenses designed to address myopia progression.

Major players in the myopia treatment market are Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Johnson & Johnson Vision Care Inc., CooperVision Inc., Menicon Co. Ltd., Topcon Healthcare Inc., Essilor Ltd., NIDEK CO. LTD., SightGlass Vision Inc., SCHWIND eye-tech-solutions GmbH, Visioneering Technologies Inc., MEDMONT INTERNATIONAL PTY LTD., Vyluma Inc., Haag-Streit Holding AG, NovaSight Ltd., Euclid Vision Corporation, Treehouse Eyes LLC, Sydnexis Inc., Neurobit Technologies Co. Ltd., Kubota Pharmaceutical Holdings Co. Ltd.

Asia Pacific was the largest region in the myopia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in myopia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the myopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia treatment market consists of revenues earned by entities by providing services such as myopia control programs, vision therapy, and lifestyle and behavioral guidance. The market value includes the value of related goods sold by the service provider or included within the service offering. The myopia treatment market includes sales of prescription glasses, atropine drops, and myopia control glasses. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for myopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Simple Myopia; High Myopia; Pathological Myopia
• 2) By Treatment: Eyeglasses; Contact Lenses; Refractive Surgery; Laser-Assisted In Situ Keratomileusis (LASIK); Photorefractive Keratectomy (PRK); Orthokeratology (Ortho-K)
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
• 5) By End-User: Hospital Or Clinical Laboratories; Physician Offices; Reference Laboratories; Other End-Users
• Subsegments:
• 1) By Simple Myopia: Mild Myopia; Moderate Myopia
• 2) By High Myopia: Severe Myopia; Very Severe Myopia
• 3) By Pathological Myopia: Degenerative Myopia; Malignant Myopia
• Companies Mentioned: Regeneron Pharmaceuticals Inc.; Alcon Inc.; Bausch Health Companies Inc.; Hoya Corporation; Johnson & Johnson Vision Care Inc.; CooperVision Inc.; Menicon Co. Ltd.; Topcon Healthcare Inc.; Essilor Ltd.; NIDEK CO. LTD.; SightGlass Vision Inc.; SCHWIND eye-tech-solutions GmbH; Visioneering Technologies Inc.; MEDMONT INTERNATIONAL PTY LTD.; Vyluma Inc.; Haag-Streit Holding AG; NovaSight Ltd.; Euclid Vision Corporation; Treehouse Eyes LLC; Sydnexis Inc.; Neurobit Technologies Co. Ltd.; Kubota Pharmaceutical Holdings Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.